Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme
Author:
Funder
Natural Science and Engineering Research Council of Canada
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
https://link.springer.com/content/pdf/10.1007/s11239-023-02837-3.pdf
Reference30 articles.
1. Chan NC, Eikelboom JW, Weitz JI (2016) Evolving treatments for arterial and venous thrombosis: role of the direct oral anticoagulants. Circ Res 118:1409–1424. https://doi.org/10.1161/CIRCRESAHA.116.306925
2. Chen A, Stecker E, Warden BA (2020) Direct oral anticoagulant use: a practical guide to Common Clinical Challenges. J Am Heart Assoc 9:e017559. https://doi.org/10.1161/JAHA.120.017559
3. Hoffman M, Monroe DM (2001) A cell-based model of hemostasis. Thromb Haemost 85:958–965
4. Hoffman M, Monroe DM (2007) Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am 21:1–11. https://doi.org/10.1016/j.hoc.2006.11.004
5. Bajzar L, Manuel R, Nesheim ME (1995) Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 270:14477–14484
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3